These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. eComment: Systemic thrombolysis with alteplase in impending paradoxical embolism. Misfeld M, Hanke T. Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):714. PubMed ID: 19773241 [No Abstract] [Full Text] [Related]
3. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator? Hassan AE, Zacharatos H, Hassanzadeh B, El-Gengaihy A, AlKawi A, Shhadeh A, Kirmani JF. J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087 [Abstract] [Full Text] [Related]
5. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ. Cerebrovasc Dis; 2013 Mar; 35(5):461-8. PubMed ID: 23735898 [Abstract] [Full Text] [Related]
7. A model to prevent fibrinolysis in patients with stroke mimics. Chang J, Teleb M, Yang JP, Alderazi YJ, Chapple K, Frey JL, Restrepo L. J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609 [Abstract] [Full Text] [Related]
8. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment. Nesi M, Lucente G, Nencini P, Fancellu L, Inzitari D. J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114 [Abstract] [Full Text] [Related]
9. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study. Berlet MH, Stambo GW, Kelley M, Van Epps K, Woeste T, Steffen D. J Stroke Cerebrovasc Dis; 2014 Feb; 23(5):869-78. PubMed ID: 24011839 [Abstract] [Full Text] [Related]
10. Stroke outcomes of Japanese patients with major cerebral artery occlusion in the post-alteplase, pre-MERCI era. Endo K, Koga M, Sakai N, Yamagami H, Furui E, Matsumoto Y, Shiokawa Y, Yoshimura S, Okada Y, Nakagawara J, Hyogo T, Hasegawa Y, Nagashima H, Fujinaka T, Hyodo A, Terada T, Toyoda K, Joint Research Group from JR-NET2 and SAMURAI Study Investigators. J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):805-10. PubMed ID: 22721823 [Abstract] [Full Text] [Related]
11. Successful administration of alteplase in a venous thromboembolism crossing through a patent foramen ovale. Ruiz-Bailén M, Ramos-Cuadra JA, Machado-Casas J, Rucabado-Aguilar L. Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):712-3. PubMed ID: 19592415 [Abstract] [Full Text] [Related]
14. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality? Fuentes B, Masjuan J, Alonso de Leciñana M, Simal P, Egido J, Díaz-Otero F, Gil-Nuñez A, Martínez-Sánchez P, Díez-Tejedor E, Madrid Stroke Network. Int J Stroke; 2012 Jan; 7(1):7-13. PubMed ID: 22017881 [Abstract] [Full Text] [Related]
16. Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen Ovale. Matsuzono K, Arai N, Suzuki M, Kim Y, Ozawa T, Mashiko T, Shimazaki H, Koide R, Matsuura T, Fujimoto S. J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e110-e112. PubMed ID: 29402614 [Abstract] [Full Text] [Related]
18. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report. Matsuzaki T, Yoshino A, Sakatani K, Katayama Y. J Stroke Cerebrovasc Dis; 2011 Jun; 20(3):269-72. PubMed ID: 20630773 [Abstract] [Full Text] [Related]